Dimerix begins recruiting young kidney disease patients in Mexico for Phase 3
Dimerix Limited (ASX:DXB) has confirmed it's begun recruiting adolescent kidney disease patients in Mexico, now that its first Phase 3 clinical trial location has been selected.
SFN
0.00%
0.0¢
![](/images/icons/chart-icon.png)
STANFIELD FUNDS MANAGEMENT LIMITED - Corporate Spotlight
Currently unlisted.
Add to my watchlist
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
No Corporate Spotlight currently available.